Showing results (1851-1860 of 3,014) with videos related to

Sort By:
Pageof 302
International Journal of Molecular Sciences|July 26, 2020
Investigating the Vascular Toxicity Outcomes of the Irreversible Proteasome Inhibitor CarfilzomibPanagiotis Efentakis, Hendrik Doerschmann, Claudius Witzler, et al.
European Journal of Clinical Investigation|July 30, 2020
Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysisStefano Figliozzi, Pier Giorgio Masci, Navid Ahmadi, et al.
Insights Into Imaging|March 29, 2022
The utility of splenic imaging parameters in cardiac magnetic resonance for the diagnosis of immunoglobulin light-chain amyloidosisNiki Lama, Alexandros Briasoulis, Efstratios Karavasilis, et al.
EFORT Open Reviews|October 12, 2018
Current concepts for the evaluation and management of diabetic foot ulcersAndreas F Mavrogenis, Panayiotis D Megaloikonomos, Thekla Antoniadou, et al.
Antibiotics (Basel, Switzerland)|August 28, 2025
Ceftazidime-Avibactam Plus Aztreonam for the Treatment of Blood Stream Infection Caused by Klebsiella pneumoniae Resistant to All Beta-Lactame/Beta-Lactamase Inhibitor CombinationsKonstantinos Mantzarlis, Efstratios Manoulakas, Dimitrios Papadopoulos, et al.
Pacing and Clinical Electrophysiology : PACE|May 10, 2014
Association of quality of life, anxiety, and depression with left atrial ablation outcomesMichael Efremidis, Konstantinos P Letsas, Louiza Lioni, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 30, 2004
Pulsed cyclophosphamide, thalidomide and dexamethasone: an oral regimen for previously treated patients with multiple myelomaMeletios A Dimopoulos, George Hamilos, Athanasios Zomas, et al.
Blood Cancer Journal|February 7, 2025
The clinical journey of belantamab mafodotin in relapsed or refractory multiple myeloma: lessons in drug developmentPralay Mukhopadhyay, Hesham A Abdullah, Joanna B Opalinska, et al.
Journal of Clinical Medicine|November 9, 2024
Trabecular Bone Score as a Complementary Tool for the Assessment of Bone Mineral Density in Patients with Asymptomatic Monoclonal GammopathiesStyliani Drakoulidou, Ioannis Ntanasis-Stathopoulos, Aikaterini Kyritsi, et al.
Pageof 302